Serina Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | -15.7% | -0.6% | +23.8% | -96.9% | +6,316.2% | -85.6% | +530.6% | -98.2% | +132.1% | |
| – | -24.8% | +22.8% | +18.7% | +28.3% | +196.5% | -96.2% | -37.9% | +115.6% | -56.2% | |
| – | -4.8% | -22.8% | +31.4% | -268.2% | – | – | +512.6% | -104.5% | – | |
| – | -33.1% | +1.6% | -0.1% | -33.0% | +6.0% | -58.6% | +51.8% | +213.2% | +75.9% | |
| – | – | – | – | – | – | -0.7% | +202.1% | +147.1% | +14.3% | |
| – | -32.3% | +20.4% | +20.8% | -30.9% | -85.9% | +113.5% | +123.5% | +173.1% | +42.1% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | -52.0% | – | – | – | -99.2% | +413.2% | +3,414.3% | -5.7% | -59.5% | |
| – | – | – | – | – | – | – | – | -312.7% | – | |
| – | – | – | – | +214.9% | -99.3% | -8,181.4% | – | – | – | |
| – | – | – | – | – | – | – | – | -311.4% | – | |
| – | – | – | – | – | – | – | – | -277.2% | – |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.